Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-06-30 4:02 pm Sale | 13D | AQUABOUNTY TECHNOLOGIES INC CO AQB | KIRK RANDAL J | 3,493,643 4.9% | -991,659 (-22.11%) | View |
| 2023-06-07 5:27 pm Sale | 13D | AQUABOUNTY TECHNOLOGIES INC CO AQB | KIRK RANDAL J | 4,485,302 6.3% | -858,700 (-16.07%) | View |
| 2023-01-31 4:01 pm Purchase | 13D | INTREXON CORP XON | KIRK RANDAL J | 96,360,443 38.3% | 11,555,166 (+13.63%) | View |
| 2022-10-07 4:42 pm Purchase | 13D | INTREXON CORP XON | KIRK RANDAL J | 84,805,277 40.7% | 2,983,114 (+3.65%) | View |
| 2021-11-24 4:01 pm Sale | 13D | AQUABOUNTY TECHNOLOGIES INC CO AQB | KIRK RANDAL J | 5,344,002 7.5% | -12,875,822 (-70.67%) | View |
| 2020-12-21 4:01 pm Sale | 13D | INTREXON CORP XON | KIRK RANDAL J | 81,822,163 43.6% | -2,177,837 (-2.59%) | View |
| 2020-12-21 4:01 pm Sale | 13D | AQUABOUNTY TECHNOLOGIES INC CO AQB | KIRK RANDAL J | 18,219,824 33.1% | -34,088 (-0.19%) | View |
| 2020-10-08 5:28 pm Sale | 13D | ORAGENICS INC ONI | KIRK RANDAL J | 230,792 0.4% | -4,381,374 (-95.00%) | View |
| 2020-08-13 4:43 pm Purchase | 13D | INTREXON CORP XON | KIRK RANDAL J | 84,000,000 48.7% | 2,476,064 (+3.04%) | View |
| 2020-08-13 4:27 pm Purchase | 13D | AQUABOUNTY TECHNOLOGIES INC CO AQB | KIRK RANDAL J | 18,253,912 42.3% | 4,002,159 (+28.08%) | View |
| 2020-03-02 5:05 pm Purchase | 13D | ORAGENICS INC ONI | KIRK RANDAL J | 4,612,166 9.9% | 4,610,233 (+238501.45%) | View |
| 2020-02-18 4:01 pm Purchase | 13D | AQUABOUNTY TECHNOLOGIES INC CO AQB | KIRK RANDAL J | 14,251,753 44.6% | 5,175,000 (+57.01%) | View |
| 2020-02-04 4:59 pm Purchase | 13D | INTREXON CORP XON | KIRK RANDAL J | 81,523,936 48.2% | 81,523,936 (New Position) | View |
| 2020-01-06 4:01 pm Sale | 13D | INTREXON CORP XON | KIRK RANDAL J | 0 0% | -74,378,292 (Position Closed) | View |
| 2019-11-05 4:53 pm Sale | 13D | HALOZYME THERAPEUTICS INC HTI | KIRK RANDAL J | 7,046,385 4.8% | -3,497,856 (-33.17%) | View |
| 2019-10-31 07:47 am Unchanged | 13D | AQUABOUNTY TECHNOLOGIES INC CO AQB | KIRK RANDAL J | 9,076,753 42% | 0 (Unchanged) | View |
| 2019-09-17 4:33 pm Sale | 13D | FIBROCELL SCIENCE INC FCSC | KIRK RANDAL J | 0 0% | -10,994,686 (Position Closed) | View |
| 2019-07-03 4:01 pm Sale | 13D | HALOZYME THERAPEUTICS INC HTI | KIRK RANDAL J | 10,544,241 7.2% | -1,567,633 (-12.94%) | View |
| 2019-06-10 5:24 pm Purchase | 13D | INTREXON CORP XON | KIRK RANDAL J | 74,378,292 46.1% | 2,198,939 (+3.05%) | View |
| 2019-06-07 5:10 pm Sale | 13D | HALOZYME THERAPEUTICS INC HTI | KIRK RANDAL J | 12,111,874 8.3% | -1,980,897 (-14.06%) | View |